Rigel Pharmaceuticals Inc (RIGL)
Stock-Based Compensation
$6.84M
Quarterly · Period ending: · USD
RIGL Stock-Based Compensation
Latest reported$6.84Mperiod ending
Latest reported$6.84Mperiod ending
RIGL Quarterly Stock-Based Comp ($1.09M → $6.84M)
Quarterly stock-based compensation
High-resolution chart · PNG
RIGL stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 6,844,000 | |
| 3,456,000 | |
| 2,748,000 | |
| 3,363,000 | |
| 3,276,000 | |
| 3,324,000 | |
| 2,087,000 | |
| 2,644,000 | |
| 2,528,000 | |
| 5,134,000 | |
| 1,933,000 | |
| 1,943,000 | |
| 2,172,000 | |
| 2,758,000 | |
| 4,080,000 | |
| 2,707,000 | |
| 2,391,000 | |
| 3,207,000 | |
| 2,339,000 | |
| 2,202,000 | |
| 2,306,000 | |
| 2,639,000 | |
| 1,632,000 | |
| 1,884,000 | |
| 1,757,000 | |
| 2,024,000 | |
| 1,411,000 | |
| 2,098,000 | |
| 2,653,000 | |
| 2,953,000 | |
| 2,057,000 | |
| 2,995,000 | |
| 1,112,000 | |
| 1,540,000 | |
| 3,059,000 | |
| 873,000 | |
| 1,100,000 | |
| 955,000 | |
| 2,666,000 | |
| 1,215,000 | |
| 2,014,000 | |
| 1,438,000 | |
| 1,625,000 | |
| 1,815,000 | |
| 1,909,000 | |
| 2,054,000 | |
| 3,211,000 | |
| 2,080,000 | |
| 2,132,000 | |
| 2,364,000 | |
| 1,563,000 | |
| 2,063,000 | |
| 1,747,000 | |
| 1,793,000 | |
| 3,263,000 | |
| 3,245,000 | |
| 3,011,000 | |
| 3,098,000 | |
| 3,041,000 | |
| 3,090,000 | |
| 3,200,000 | |
| 3,837,000 | |
| 3,801,000 | |
| 3,767,000 | |
| 3,701,000 | |
| 5,167,000 | |
| 3,781,000 | |
| 3,532,000 | |
| 3,859,000 | |
| 2,266,000 | |
| 0 | |
| 0 | |
| 0 | |
| 5,846,000 | |
| 0 | |
| 0 | |
| 0 | |
| 2,622,000 | |
| 12,579,000 | |
| 0 | |
| 0 | |
| 3,561,000 | |
| 30,000 | |
| 0 | |
| 0 | |
| 6,000 | |
| 127,000 | |
| 0 | |
| -810,000 | |
| 54,000 | |
| 0 | |
| 0 | |
| -290,000 | |
| 224,000 | |
| 0 | |
| 0 | |
| 0 | |
| 480,000 | |
| 2,633,000 | |
| 0 |